Intel partners with 3 UK institutions for AI cancer detection

Intel joined forces with three English institutions to identify cancer cells using artificial intelligence.

Advertisement

University Hospitals Coventry and Warwickshire NHS Trust, Coventry-based University of Warwick and London-based Alan Turing Institute will work with Intel to create a computational model that recognizes different types of lung cancer.

The institutions will develop the model on a large-scale digital repository of tumor images created by University of Warwick’s tissue image analytics laboratory. University Hospitals Coventry and Warwickshire NHS Trust will also annotate these images to inform the algorithm.

The collaboration is part of Alan Turing Institute’s partnership with Intel, which launched in April and focuses on computational data science.

More articles on health IT:
Homeland Security: Year-long malware campaign targets healthcare, public health sectors
Companies seek analytic, documentation skills for HIM jobs, AHIMA finds
Top health IT vendors for 5 uses: data analytics, patient engagement & more

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.